Cell Line Development Market Size

Cell Line Development Market Size

Cell Line Development Market size was valued at around USD 5.8 billion in 2021 and is expected to witness around 10.1% CAGR from 2022 to 2028. Cancer has become more common over the last decade due to changes in food habits, lack of physical activities, and overall lifestyle. Furthermore, technological advancements along with growing vaccine production will increase the demand for cell line development.

To get key market trends

  Download Free Sample

Additionally, rising innovations in biologics and increased demand for targeted therapies like monoclonal antibodies will further boost the market. The monoclonal antibodies are widely used in treatment of cancer. The World Health Organization (WHO) declared COVID-19 as a pandemic in March 2020. Since then, the mortality rate due to chronic conditions has increased exponentially. Thus, the impact of COVID-19 on the cell line development industry is observed to be positive. The pandemic called for the need of vaccines in a large scale thus boosting the production requiring cell line development procedures.

Cell line development is a process of developing highly productive, stable cell lines essential for the production and manufacturing of bio-therapeutics. These are single-celled derived and used to produce vaccines, monoclonal antibodies, and fusion proteins. The development process involves screening thousands of clones to find those that yield a high amount of biproduct and exhibit desired critical quality attributes. These properties of cell lines increase their use in the production of biological drug substances. Such scenarios increase the demand for cell line development.